← Back to explorer

Dostarlimab 50 mg/ml sol. Inj. Frs. 10 ml IV

TED · 370892-2026can-standardawardedNo deadline given

Buyer

NameInstituto Português de Oncologia do Porto Francisco Gentil, EPE

CountryPT

Published2026-06-01

Deadline—

Value

Estimated—

Awarded€100 · 100 EUR

WinnerGlaxoSmithkline - Produtos Farmacêuticos, Lda.

See this firm's wins →

CPV codes

33600000 Medical equipment & pharmaceuticals

Description

Dostarlimab 50 mg/ml sol. Inj. Frs. 10 ml IV

Similar tenders

Closest by meaning — across languages, via embeddings.

PublishedTitleBuyerMatch
2026-06-242023/0491 - IPILIMUMAB [5 MG/ML 10 ML CONC P/ SOL P/ PERF FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT91%
2026-06-242023/0491 - IPILIMUMAB [5 MG/ML 10 ML CONC P/ SOL P/ PERF FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT91%
2026-05-122023/0491 - DARATUMUMAB [120 MG/ ML 15 ML SOL INJ FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT91%
2026-06-022023/0491 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT91%
2026-06-022023/0491 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT91%
2026-06-092025/1746 - EMICIZUMAB [150 MG/ML 0,7 ML SOL INJ FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT90%

Source

View the official notice on TED ↗